{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T02:34:34Z","timestamp":1794623674512,"version":"4.9.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T00:00:00Z","timestamp":1646265600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T00:00:00Z","timestamp":1646265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Uterine Artery Embolization (UAE) and Magnetic Resonance guided High Intensity Focused Ultrasound (MRgHIFU) are two noninvasive treatments for uterine leiomyoma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This systematic review, following PRISMA guidelines, analyzed the effectiveness of two treatments by comparing percent fibroid volume shrinkage immediately after the procedure and after 3, 6, 12 and 24\u00a0months of follow-up and also assessed and compared common complications following treatment. The search utilized Science Direct, PubMed, MEDLINE, Google Scholar and BioMed Central databases, selecting manuscripts published during the period 2000 and 2020. Studies with premenopausal patients with previous treatments for uterine leiomyoma and\/or with other pelvic diseases were excluded.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Twenty-nine papers satisfied inclusion and exclusion criteria. Results were pooled and stratified by treatment and follow-up time. Weighted fibroid volume percent shrinkage after UAE was statistically significantly greater than MRgHIFU at 6, 12, and 24\u00a0months follow-up times. However, UAE had statistically significantly more complications, such as pain, nausea and vomiting. However, this study cannot conclude that UAE is more effective than MRgHIFU due to confounding factors.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12905-022-01627-y","type":"journal-article","created":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T09:04:43Z","timestamp":1646298283000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Comparison of two invasive non-surgical treatment options for uterine myomas: uterine artery embolization and magnetic resonance guided high intensity focused ultrasound\u2014systematic review"],"prefix":"10.1186","volume":"22","author":[{"given":"Madina","family":"Yerezhepbayeva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milan","family":"Terzic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulzhanat","family":"Aimagambetova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byron","family":"Crape","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,3]]},"reference":[{"issue":"2","key":"1627_CR1","doi-asserted-by":"publisher","first-page":"192","DOI":"10.5468\/ogs.2018.61.2.192","volume":"61","author":"GS Sohn","year":"2018","unstructured":"Sohn GS, Cho S, Kim YM, Cho CH, Kim MR, Lee SR, Working Group of Society of Uterine Leiomyoma. Current medical treatment of uterine fibroids. Obstet Gynecol Sci. 2018;61(2):192\u2013201. https:\/\/doi.org\/10.5468\/ogs.2018.61.2.192.","journal-title":"Obstet Gynecol Sci"},{"issue":"2","key":"1627_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.jmig.2017.08.642","volume":"25","author":"SK Laughlin-Tommaso","year":"2018","unstructured":"Laughlin-Tommaso SK. Non-surgical management of myomas. J Minim Invasive Gynecol. 2018;25(2):229\u201336. https:\/\/doi.org\/10.1016\/j.jmig.2017.08.642.","journal-title":"J Minim Invasive Gynecol"},{"issue":"2","key":"1627_CR3","first-page":"157","volume":"37","author":"GA Vilos","year":"2015","unstructured":"Vilos GA, Allaire C, Laberge PY, Leyland N. The management of uterine myomas. J Obstet Gynecol. 2015;37(2):157\u201378.","journal-title":"J Obstet Gynecol"},{"issue":"S3","key":"1627_CR4","first-page":"30","volume":"124","author":"M Zou","year":"2017","unstructured":"Zou M, Chen L, Wu C, Hu C, Xiong Y. Pregnancy outcomes in patients with uterine fibroids treated with ultrasound-guided high-intensity focused ultrasound. Int J Obstet Gynecol. 2017;124(S3):30\u20135.","journal-title":"Int J Obstet Gynecol"},{"issue":"4","key":"1627_CR5","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.ogc.2012.09.005","volume":"39","author":"XC Guo","year":"2012","unstructured":"Guo XC, Segars JH. The impact and management of fibroids for fertility: an evidence-based approach. Obstet Gynecol Clin N Am. 2012;39(4):521\u201333.","journal-title":"Obstet Gynecol Clin N Am"},{"key":"1627_CR6","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/4593875","author":"A El-Balat","year":"2018","unstructured":"El-Balat A, DeWilde RL, Schmeil I, Tahmasbi-Rad M, Bogdanyova S, Fathi A, Becker S. Modern myoma treatment in the last 20 years: a review of the literature. BioMed Res Int. 2018. https:\/\/doi.org\/10.1155\/2018\/4593875.","journal-title":"BioMed Res Int"},{"issue":"1","key":"1627_CR7","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1080\/02656736.2018","volume":"36","author":"M Taheri","year":"2019","unstructured":"Taheri M, Galo L, Potts C, Sakhel K, Quinn SD. Nonresective treatments for uterine fibroids: a systematic review of uterine and fibroid volume reductions. Int J Hyperth. 2019;36(1):295\u2013301. https:\/\/doi.org\/10.1080\/02656736.2018.","journal-title":"Int J Hyperth"},{"key":"1627_CR8","unstructured":"StataCorp LLC. Stata Statistical Software: Release 16. https:\/\/www.stata.com\/support\/faqs\/resources\/citing-software-documentation-faqs\/#:~:text=2019.,Station%2CTX%3AStataCorpLLC.&text=StataCorp.-2017 (2019)."},{"issue":"3","key":"1627_CR9","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1148\/radiology.214.3.r00fe07729","volume":"214","author":"PR Burn","year":"2000","unstructured":"Burn PR, McCall JM, Chinn RJ, Vashisht A, Smith JR, Healy JC. Uterine fibroleiomyoma: MR imaging appearances before and after embolization of uterine arteries. Radiology. 2000;214(3):729\u201334. https:\/\/doi.org\/10.1148\/radiology.214.3.r00fe07729.","journal-title":"Radiology"},{"issue":"8","key":"1627_CR10","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/s1051-0443(07)61337-2","volume":"11","author":"AR Roth","year":"2000","unstructured":"Roth AR, Spies JB, Walsh SM, Wood BJ, Gomez-Jorge J, Levy EB. Pain after uterine artery embolization for leiomyomata: can its severity be predicted and does severity predict outcome? J Vasc Interv Radiol. 2000;11(8):1047\u201352. https:\/\/doi.org\/10.1016\/s1051-0443(07)61337-2.","journal-title":"J Vasc Interv Radiol"},{"issue":"7","key":"1627_CR11","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1067\/mob.2001.114863","volume":"184","author":"A Klein","year":"2001","unstructured":"Klein A, Schwartz M. Uterine artery embolization for the treatment of uterine fibroids: an outpatient procedure. Am J Obstet Gynecol. 2001;184(7):1556\u201363. https:\/\/doi.org\/10.1067\/mob.2001.114863.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"1627_CR12","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0015-0282(02)04399-6","volume":"79","author":"E Zupi","year":"2003","unstructured":"Zupi E, Pocek M, Dauri M, Marconi D, Sbracia M, Piccione E, Simonetti G. Selective uterine artery embolization in the management of uterine myomas. Fertil Steril. 2003;79(1):107\u201311.","journal-title":"Fertil Steril"},{"issue":"8","key":"1627_CR13","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1097\/01.RVI.0000136982.42548.5D","volume":"15","author":"JB Spies","year":"2004","unstructured":"Spies JB, Allison S, Flick P, McCullough M, Sterbis K, Cramp M, Bruno J, Jha R. Polyvinyl alcohol particles and tris-acryl gelatin microspheres for uterine artery embolization for leiomyomas: results of a randomized comparative study. J Vasc Interv Radiol. 2004;15(8):793\u2013800.","journal-title":"J Vasc Interv Radiol"},{"issue":"4","key":"1627_CR14","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1080\/02841850600557117","volume":"47","author":"M Harman","year":"2006","unstructured":"Harman M, Zetero\u011elu S, Arslan M, \u015eeng\u00fcl M, Etlik O. Predictive value of magnetic resonance imaging signal and contrast-enhancement characteristics on post-embolization volume reduction of uterine fibroids. Acta Radiol. 2006;47(4):427\u201335.","journal-title":"Acta Radiol"},{"issue":"6","key":"1627_CR15","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.jvir.2009.01.029","volume":"20","author":"JM Pisco","year":"2009","unstructured":"Pisco JM, Bilhim T, Duarte M, Santos D. Management of uterine artery embolization for fibroids as an outpatient procedure. J Vasc Interv Radiol. 2009;20(6):730\u20135. https:\/\/doi.org\/10.1016\/j.jvir.2009.01.029.","journal-title":"J Vasc Interv Radiol"},{"issue":"4","key":"1627_CR16","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.jvir.2009.12.388","volume":"21","author":"NNN Naguib","year":"2010","unstructured":"Naguib NNN, Mbalisike E, Nour-Eldin NEA, Jost A, Lehnert T, Ackermann H, Vogl TJ. Leiomyoma volume changes at follow-up after uterine artery embolization: correlation with the initial leiomyoma volume and location. J Vasc Interv Radiol. 2010;21(4):490\u20135. https:\/\/doi.org\/10.1016\/j.jvir.2009.12.388.","journal-title":"J Vasc Interv Radiol"},{"key":"1627_CR17","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s00270-010-9986-8","volume":"34","author":"U Stampfl","year":"2011","unstructured":"Stampfl U, Radeleff B, Sommer C, Stampfl S, Dahlke A, Bellemann N, Kauczor HU, Richter GM. Midterm results of uterine artery embolization using narrow-size calibrated embozene microspheres. Cardiovasc Interv Radiol. 2011;34:295\u2013305.","journal-title":"Cardiovasc Interv Radiol"},{"issue":"1","key":"1627_CR18","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jvir.2010.09.018","volume":"22","author":"T Bilhim","year":"2011","unstructured":"Bilhim T, Pisco JM, Duarte M, Oliveira AG. Polyvinyl alcohol particle size for uterine artery embolization: a prospective randomized study of initial use of 350\u2013500 \u03bcm particles versus initial use of 500\u2013700 \u03bcm particles. J Vasc Interv Radiol. 2011;22(1):21\u20137. https:\/\/doi.org\/10.1016\/j.jvir.2010.09.018.","journal-title":"J Vasc Interv Radiol"},{"issue":"1","key":"1627_CR19","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s00404-012-2512-2","volume":"287","author":"M Redecha","year":"2013","unstructured":"Redecha M, Mi\u017ei\u010dkov\u00e1 M, Javorka V, Redecha M, Kurimsk\u00e1 S, Holom\u00e1\u0148 K. Pregnancy after uterine artery embolization for the treatment of myomas: a case series. Arch Gynecol Obstet. 2013;287(1):71\u20136. https:\/\/doi.org\/10.1007\/s00404-012-2512-2.","journal-title":"Arch Gynecol Obstet"},{"issue":"6","key":"1627_CR20","doi-asserted-by":"publisher","first-page":"364","DOI":"10.3109\/13645706.2013.826674","volume":"22","author":"YG Song","year":"2013","unstructured":"Song YG, Jang H, Park KD, Kim MD, Kim CW. Non spherical polyvinyl alcohol versus gelatin sponge particles for uterine artery embolization for symptomatic fibroids. Minim Invasive Ther Allied Technol. 2013;22(6):364\u201371. https:\/\/doi.org\/10.3109\/13645706.2013.826674.","journal-title":"Minim Invasive Ther Allied Technol"},{"key":"1627_CR21","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ejrad.2018.10.017","volume":"109","author":"JK Yoon","year":"2018","unstructured":"Yoon JK, Han K, Kim MD, Kim GM, Kwon JH, Won JY, Lee DY. Five-year clinical outcomes of uterine artery embolization for symptomatic leiomyomas: an analysis of risk factors for reintervention. Eur J Radiol. 2018;109:83\u20137. https:\/\/doi.org\/10.1016\/j.ejrad.2018.10.017.","journal-title":"Eur J Radiol"},{"issue":"4","key":"1627_CR22","doi-asserted-by":"publisher","first-page":"165","DOI":"10.4103\/GMIT.GMIT_50_19","volume":"8","author":"T Ukybassova","year":"2019","unstructured":"Ukybassova T, Terzic M, Dotlic J, Imankulova B, Terzic S, Shauyen F, Garzon S, Guo L, Sui L. Evaluation of uterine artery embolization on myoma shrinkage: results from a large cohort analysis. Gynecol Minim Invasive Ther. 2019;8(4):165\u201371. https:\/\/doi.org\/10.4103\/GMIT.GMIT_50_19.","journal-title":"Gynecol Minim Invasive Ther"},{"issue":"6","key":"1627_CR23","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.2214\/ajr.183.6.01831713","volume":"183","author":"J Hindley","year":"2004","unstructured":"Hindley J, Gedroyc WM, Regan L, Stewart E, Tempany C, Hynnen K, Macdanold N, Inbar Y, Itzchak Y, Rabinovici J, Kim K, Geschwind JF, Hesley G, Gostout B, Ehrenstein T, Hengst S, Sklair-Levy M, Shushan A, Jolesz F. MRI guidance of focused ultrasound therapy of uterine fibroids: early results. Am J Roentgenol. 2004;183(6):1713\u20139. https:\/\/doi.org\/10.2214\/ajr.183.6.01831713.","journal-title":"Am J Roentgenol"},{"issue":"4","key":"1627_CR24","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s11604-007-0215-6","volume":"26","author":"K Mikami","year":"2008","unstructured":"Mikami K, Murakami T, Okada A, Osuga K, Tomoda K, Nakamura H. Magnetic resonance imaging-guided focused ultrasound ablation of uterine fibroids: early clinical experience. Radiat Med. 2008;26(4):198\u2013205. https:\/\/doi.org\/10.1007\/s11604-007-0215-6.","journal-title":"Radiat Med"},{"issue":"2","key":"1627_CR25","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.ejogrb.2007.10.018","volume":"139","author":"Y Morita","year":"2008","unstructured":"Morita Y, Ito N, Hikida H, Takeuchi S, Nakamura K, Ohashi H. Non-invasive magnetic resonance imaging-guided focused ultrasound treatment for uterine fibroids\u2013early experience. Eur J Obstet Gynecol Reprod Biol. 2008;139(2):199\u2013203.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"5","key":"1627_CR26","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1002\/uog.4099","volume":"30","author":"J Rabinovici","year":"2007","unstructured":"Rabinovici J, Inbar Y, Revel A, Zalel Y, Gomori JM, Itzchak Y, Schiff E, Yagel S. Clinical improvement and shrinkage of uterine fibroids after thermal ablation by magnetic resonance-guided focused ultrasound surgery. Ultrasound Obstet Gynecol. 2007;30(5):771\u20137.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"1","key":"1627_CR27","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1148\/radiol.2491071600","volume":"249","author":"ZM L\u00e9n\u00e1rd","year":"2008","unstructured":"L\u00e9n\u00e1rd ZM, McDannold NJ, Fennessy FM, Stewart EA, Jolesz FA, Hynynen K, Tempany CM. Uterine leiomyomas: MR imaging-guided focused ultrasound surgery-imaging predictors of success 1. Radiology. 2008;249(1):187\u201394. https:\/\/doi.org\/10.1148\/radiol.2491071600.","journal-title":"Radiology"},{"issue":"2","key":"1627_CR28","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.ejrad.2008.11.002","volume":"73","author":"L Zhang","year":"2010","unstructured":"Zhang L, Chen WZ, Liu YJ, Hu X, Zhou K, Chen L, Peng S, Zhu H, Zou HL, Bai J, Wang ZB. Feasibility of magnetic resonance imaging-guided high intensity focused ultrasound therapy for ablating uterine fibroids in patients with bowel lies anterior to uterus. Eur J Radiol. 2010;73(2):396\u2013403. https:\/\/doi.org\/10.1016\/j.ejrad.2008.11.002.","journal-title":"Eur J Radiol"},{"issue":"5","key":"1627_CR29","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1002\/uog.7455","volume":"34","author":"K Funaki","year":"2009","unstructured":"Funaki K, Fukunishi H, Sawada K. Clinical outcomes of magnetic resonance-guided focused ultrasound surgery for uterine myomas: 24-month follow-up. Ultrasound Obstet Gynecol. 2009;34(5):584\u20139. https:\/\/doi.org\/10.1002\/uog.7455.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"8","key":"1627_CR30","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.acra.2011.03.008","volume":"18","author":"HS Kim","year":"2011","unstructured":"Kim HS, Baik JH, Pham LD, Jacobs MA. MR-guided high-intensity focused ultrasound treatment for symptomatic uterine leiomyomata: long-term outcomes. Acad Radiol. 2011;18(8):970\u20136. https:\/\/doi.org\/10.1016\/j.acra.2011.03.008.","journal-title":"Acad Radiol"},{"issue":"10","key":"1627_CR31","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1055\/s-0033-1335289","volume":"184","author":"H Ruhnke","year":"2013","unstructured":"Ruhnke H, Eckey T, Bohlmann MK, Beldoch MP, Neumann A, Agic A, H\u00e4gele J, Diedrich K, Barkhausen J, Hunold P. MR-guided HIFU treatment of symptomatic uterine fibroids using novel feedback-regulated volumetric ablation: effectiveness and clinical practice. Rofo. 2013;184(10):983\u201391. https:\/\/doi.org\/10.1055\/s-0033-1335289.","journal-title":"Rofo"},{"issue":"7","key":"1627_CR32","doi-asserted-by":"publisher","first-page":"764","DOI":"10.3109\/02656736.2015.1063169","volume":"31","author":"AC Thiburce","year":"2015","unstructured":"Thiburce AC, Frulio N, Hocquelet A, Maire F, Salut C, Balageas P, Bouzgarrou M, Hock\u00e9 C, Trillaud H. Magnetic resonance-guided high-intensity focused ultrasound for uterine fibroids: mid-term outcomes of 36 patients treated with the Sonalleve system. Int J Hyperther. 2015;31(7):764\u201370. https:\/\/doi.org\/10.3109\/02656736.2015.1063169.","journal-title":"Int J Hyperther"},{"issue":"5","key":"1627_CR33","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.tjog.2015.03.011","volume":"55","author":"SL Tung","year":"2016","unstructured":"Tung SL, Chou TY, Tseng HS, Lee CM. A retrospective study of magnetic resonance-guided focused ultrasound ablation for uterine myoma in Taiwan. Taiwan J Obstet Gynecol. 2016;55(5):646\u20139. https:\/\/doi.org\/10.1016\/j.tjog.2015.03.011.","journal-title":"Taiwan J Obstet Gynecol"},{"issue":"12","key":"1627_CR34","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.7863\/ultra.14.12080","volume":"34","author":"Y Xu","year":"2015","unstructured":"Xu Y, Fu Z, Yang L, Huang Z, Chen WZ, Wang Z. Feasibility, safety, and efficacy of accurate uterine fibroid ablation using magnetic resonance imaging-guided high-intensity focused ultrasound with shot sonication. J Ultrasound Med. 2015;34(12):2293\u2013303. https:\/\/doi.org\/10.7863\/ultra.14.12080.","journal-title":"J Ultrasound Med"},{"issue":"1","key":"1627_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40349-016-0072-9","volume":"4","author":"R Chen","year":"2016","unstructured":"Chen R, Keserci B, Bi H, Han X, Wang X, Bai W, Wang Y, Yang X, Yang J, Wei J, Sepp\u00e4l\u00e4 M, Viitala A, Liao Q. The safety and effectiveness of volumetric magnetic resonance-guided high-intensity focused ultrasound treatment of symptomatic uterine fibroids: early clinical experience in China. J Therap Ultrasound. 2016;4(1):1\u20139. https:\/\/doi.org\/10.1186\/s40349-016-0072-9.","journal-title":"J Therap Ultrasound"},{"issue":"3","key":"1627_CR36","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.fertnstert.2015.11.014","volume":"105","author":"VL Jacoby","year":"2016","unstructured":"Jacoby VL, Kohi MP, Poder L, Jacoby A, Lager J, Schembri M, Rieke V, Grady D, Vittinghoff E, Coakley FV. PROMISe trial: a pilot, randomized, placebo-controlled trial of magnetic resonance guided focused ultrasound for uterine fibroids. Fertil Steril. 2016;105(3):773\u201380.","journal-title":"Fertil Steril"},{"issue":"10","key":"1627_CR37","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/j.acra.2018.01.022","volume":"25","author":"B Keserci","year":"2018","unstructured":"Keserci B, Duc NM. Magnetic resonance imaging parameters in predicting the treatment outcome of high-intensity focused ultrasound ablation of uterine fibroids with an immediate nonperfused volume ratio of at least 90. Acad Radiol. 2018;25(10):1257\u201369. https:\/\/doi.org\/10.1016\/j.acra.2018.01.022.","journal-title":"Acad Radiol"},{"key":"1627_CR38","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.2214\/AJR.05.1383","volume":"188","author":"S Abbara","year":"2007","unstructured":"Abbara S, Nikolic B, Pelage J, Banovac F, Spies J. Frequency and extent of uterine perfusion via ovarian arteries observed during uterine artery embolization for leiomyomas. Women\u2019s Imaging. 2007;188:1558\u201363. https:\/\/doi.org\/10.2214\/AJR.05.1383.","journal-title":"Women\u2019s Imaging"},{"issue":"4","key":"1627_CR39","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1055\/s-0033-1359728","volume":"30","author":"LE Rueff","year":"2013","unstructured":"Rueff LE, Raman SS. Clinical and technical aspects of MR-guided high intensity focused ultrasound for treatment of symptomatic uterine fibroids. Semin Interv Radiol. 2013;30(4):347\u201353. https:\/\/doi.org\/10.1055\/s-0033-1359728.","journal-title":"Semin Interv Radiol"},{"key":"1627_CR40","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.2214\/AJR.11.8362","volume":"199","author":"S Toor","year":"2012","unstructured":"Toor S, Jaberi A, Macdonald B, McInnes M, Schweitzer M, Pasteur Rasuli P. Complication rates and effectiveness of uterine artery embolization in the treatment of symptomatic leiomyomas: a systematic review and meta-analysis. Am J Roentgenol. 2012;199:1153\u201363. https:\/\/doi.org\/10.2214\/AJR.11.8362.","journal-title":"Am J Roentgenol"},{"issue":"4","key":"1627_CR41","first-page":"1","volume":"15","author":"G Pron","year":"2015","unstructured":"Pron G. Magnetic resonance-guided high-intensity focused ultrasound (MRgHIFU) Treatment of symptomatic uterine fibroids: an evidence-based analysis. Ont Health Technol Assess Ser. 2015;15(4):1\u201386.","journal-title":"Ont Health Technol Assess Ser"},{"issue":"4","key":"1627_CR42","doi-asserted-by":"publisher","first-page":"247","DOI":"10.5114\/pm.2014.45001","volume":"13","author":"P Czuczwar","year":"2014","unstructured":"Czuczwar P, Wo\u017aniak S, Szkodziak P, Wo\u017aniakowska E, Paszkowski M, Wrona W, Milart P, Paszkowski T, Popajewski M. Predicting the results of uterine artery embolization: correlation between initial intramural fibroid volume and percentage volume decrease. Menopause Rev. 2014;13(4):247\u201352. https:\/\/doi.org\/10.5114\/pm.2014.45001.","journal-title":"Menopause Rev"},{"issue":"2","key":"1627_CR43","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.jmig.2020.11.004","volume":"28","author":"L Liu","year":"2021","unstructured":"Liu L, Wang T, Lei B. Uterine artery embolization compared with high-intensity focused ultrasound ablation for the treatment of symptomatic uterine myomas: a systematic review and meta-analysis. J Minim Invasive Gynecol. 2021;28(2):218\u201327. https:\/\/doi.org\/10.1016\/j.jmig.2020.11.004.","journal-title":"J Minim Invasive Gynecol"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-022-01627-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-022-01627-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-022-01627-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T09:05:36Z","timestamp":1646298336000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-022-01627-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,3]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1627"],"URL":"https:\/\/doi.org\/10.1186\/s12905-022-01627-y","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,3]]},"assertion":[{"value":"12 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable for systematic review.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable for systematic review.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no competing interests to report.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"55"}}